SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-22-017040
Filing Date
2022-04-29
Accepted
2022-04-29 17:17:59
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc10036883_10ka.htm   iXBRL 10-K/A 1216813
2 EXHIBIT 31.3 brhc10036883_ex31-3.htm EX-31.3 5523
3 EXHIBIT 31.4 brhc10036883_ex31-4.htm EX-31.4 5472
7 image00001.jpg GRAPHIC 5620
8 image00002.jpg GRAPHIC 32495
  Complete submission text file 0001140361-22-017040.txt   1624833

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atrs-20211231.xsd EX-101.SCH 3946
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20211231_lab.xml EX-101.LAB 29040
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20211231_pre.xml EX-101.PRE 20621
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc10036883_10ka_htm.xml XML 7115
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32302 | Film No.: 22877528
SIC: 3841 Surgical & Medical Instruments & Apparatus